1 |
|
LDL- influence on CD14 and TLR4
|
22 |
1.882 |
SuperPathway |
- LDL- influence on CD14 and TLR4
|
Pathways |
- LDL- influence on CD14 and TLR4
|
Genes symbols |
|
|
2 |
|
MyD88 dependent cascade initiated on endosome
|
175 |
1.790 |
Pathways |
- MyD88-independent TLR4 cascade
- Toll Like Receptor 4 (TLR4) Cascade
- TRAF6-mediated induction of TAK1 complex within TLR4 complex
- TRIF(TICAM1)-mediated TLR4 signaling
|
Genes symbols |
|
|
3 |
|
Toll-Like receptor Signaling Pathways
|
133 |
1.112 |
Pathways |
- TLR4 signaling and tolerance
|
Genes symbols |
|
|
4 |
|
DDX58/IFIH1-mediated induction of interferon-alpha/beta
|
110 |
1.112 |
Pathways |
- Immune response TLR3 and TLR4 induce TICAM1-specific signaling pathway
|
Genes symbols |
|
|
5 |
|
Programmed Cell Death
|
213 |
0.433 |
|
6 |
|
Diseases of Immune System
|
57 |
0.433 |
|
7 |
|
Circadian Clock
|
85 |
0.433 |
|
8 |
|
COVID-19 and endothelial cell senescence
|
5 |
0.433 |
|
9 |
|
Transcription_NF-kB signaling pathway
|
54 |
0.433 |
|
10 |
|
ApoE and miR-146 in inflammation and atherosclerosis
|
9 |
0.433 |
|
11 |
|
Non-genomic actions of 1,25 dihydroxyvitamin D3
|
51 |
0.433 |
|
12 |
|
Akt Signaling
|
682 |
0.433 |
|
13 |
|
Acute viral myocarditis
|
75 |
0.433 |
|
14 |
|
Extrafollicular and follicular B cell activation by SARS-CoV-2
|
74 |
0.433 |
|
15 |
|
IL-10 Pathway
|
35 |
0.433 |
|
16 |
|
Primary focal segmental glomerulosclerosis (FSGS)
|
72 |
0.433 |
|
17 |
|
Interactions between immune cells and microRNAs in tumor microenvironment
|
48 |
0.433 |
|
18 |
|
A-beta Uptake and Degradation
|
32 |
0.433 |
|
19 |
|
MIF Mediated Glucocorticoid Regulation
|
681 |
0.433 |
|
20 |
|
Cellular responses to stimuli
|
802 |
0.433 |
|
21 |
|
IL27-mediated signaling events
|
60 |
0.433 |
|
22 |
|
PI3K-Akt signaling pathway
|
390 |
0.433 |
|
23 |
|
Th17 Differentiation
|
62 |
0.433 |
|
24 |
|
NF-KappaB Family Pathway
|
242 |
0.433 |
|
25 |
|
TNF Superfamily - Human Ligand-Receptor Interactions and their Associated Functions
|
170 |
0.433 |
|
26 |
|
NF-kB (NFkB) Pathway
|
55 |
0.433 |
|
27 |
|
CASP8 activity is inhibited
|
57 |
0.433 |
|
28 |
|
Integrin family cell surface interactions
|
95 |
0.433 |
|
29 |
|
Prolactin Signaling
|
432 |
0.433 |
|
30 |
|
Host-pathogen interaction of human coronaviruses - interferon induction
|
52 |
0.433 |
|
31 |
|
MAPK Pathway
|
88 |
0.433 |
|
32 |
|
8p23.1 copy number variation syndrome
|
37 |
0.433 |
|
33 |
|
Development Slit-Robo signaling
|
121 |
0.433 |
|
34 |
|
Inflammatory bowel disease signaling
|
43 |
0.433 |
|
35 |
|
IL 10 signaling pathway
|
62 |
0.433 |
|
36 |
|
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
|
29 |
0.433 |
|
37 |
|
Antigen processing-Cross presentation
|
105 |
0.433 |
|
38 |
|
miRNA role in immune response in sepsis
|
62 |
0.433 |
|
39 |
|
Bacterial infections in CF airways
|
97 |
0.433 |
|
40 |
|
CNTF Signaling
|
149 |
0.433 |
|
41 |
|
Ebola virus infection in host
|
129 |
0.433 |
|
42 |
|
Kynurenine pathway and links to cell senescence
|
27 |
0.433 |
|
43 |
|
Neuroinflammation
|
11 |
0.433 |
|
44 |
|
MSP-RON Signaling
|
48 |
0.433 |
|
45 |
|
MIF Action Through Endocytic Pathway
|
12 |
0.433 |
|
46 |
|
Spinal cord injury
|
115 |
0.433 |
|
47 |
|
Burn wound healing
|
75 |
0.433 |
|
48 |
|
Extracellular vesicles in the crosstalk of cardiac cells
|
22 |
0.433 |
|
49 |
|
Toll-like receptor signaling pathway
|
285 |
0.433 |
|
50 |
|
Toll Comparative Pathway
|
101 |
0.433 |
|
51 |
|
Class I MHC mediated antigen processing and presentation
|
855 |
0.433 |
|
52 |
|
Infectious disease
|
1747 |
0.433 |
|
53 |
|
Innate Immune System
|
2025 |
0.433 |
|
54 |
|
Fibrin complement receptor 3 signaling pathway
|
43 |
0.433 |
|
55 |
|
Colorectal Cancer Metastasis
|
165 |
0.433 |
|
56 |
|
Corticotropin-releasing hormone signaling pathway
|
91 |
0.433 |
|
57 |
|
Cytokine production by Th17 cells in CF (Mouse model)
|
54 |
0.433 |
|